Egypt Fights Spinal Muscular Atrophy

Elsaka, Omar and Noureldean, Moneer Ayman and Gamil, Mohamed Adel and Ghazali, Mostafa Tarek and Al-Razik, Ashraf Hamada Abd and Hisham, Dalia (2021) Egypt Fights Spinal Muscular Atrophy. Asian Journal of Research and Reports in Neurology, 4 (2). pp. 122-124.

[thumbnail of 39-Article Text-67-1-10-20220901.pdf] Text
39-Article Text-67-1-10-20220901.pdf - Published Version

Download (203kB)

Abstract

SMA (spinal muscular atrophy) is a neuromuscular illness caused by a genetic (inherited) mutation that causes muscles to weaken and waste away. Motor neurons, a type of nerve cell in the spinal cord that controls muscle movement, are lost in people with SMA. Many pharmaceutical companies continue to invest heavily in research into SMA therapies. Many additional prospective medications, such as valproic acid, phenylbutyrate, hydroxyurea, albuterol, gabapentin, riluzole, olesoxime, and rapamycin, have failed to generate adequate outcomes regarding disease progression.

Item Type: Article
Subjects: Afro Asian Archive > Medical Science
Depositing User: Unnamed user with email support@afroasianarchive.com
Date Deposited: 05 Apr 2023 06:52
Last Modified: 29 Jul 2024 11:17
URI: http://info.stmdigitallibrary.com/id/eprint/206

Actions (login required)

View Item
View Item